Skip to content

Advertisement

Articles

Sort by
Page 2 of 2
  1. Content type: Research

    αVβ3, αVβ5 and α5β1 integrins are known to be involved in carcinogenesis and are overexpressed in many types of tumours compared to healthy tissues; thereby they have been selected as promising therapeutic target...

    Authors: Didier J. Colin, James A. H. Inkster, Stéphane Germain and Yann Seimbille

    Citation: EJNMMI Radiopharmacy and Chemistry 2016 1:16

    Published on:

  2. Content type: Research

    Fast implementation of positron emission tomography (PET) into clinical and preclinical studies highly demands automated synthesis for the preparation of PET radiopharmaceuticals in a safe and reproducible man...

    Authors: Shihong Li, Alexander Schmitz, Hsiaoju Lee and Robert H. Mach

    Citation: EJNMMI Radiopharmacy and Chemistry 2016 1:15

    Published on:

  3. Content type: Research

    Bisphosphonates have a high adsorption on calcified tissues and are commonly used in the treatment of bone disorder diseases. Conjugates of bisphosphonates with macrocyclic chelators open new possibilities in ...

    Authors: M. Meckel, R. Bergmann, M. Miederer and F. Roesch

    Citation: EJNMMI Radiopharmacy and Chemistry 2016 1:14

    Published on:

  4. Content type: Review

    Positron Emission Tomography (PET), as a non-invasive translatable imaging technology, can be incorporated into various stages of the CNS drug discovery process to provide valuable information for key preclini...

    Authors: Lei Zhang and Anabella Villalobos

    Citation: EJNMMI Radiopharmacy and Chemistry 2016 1:13

    Published on:

  5. Content type: Meeting abstracts

    OP03 Selective extraction of medically-related radionuclides from proton-irradiated thorium targets

    Authors: V. Radchenko, J. W. Engle, C. Roy, J. Griswold, M. F. Nortier, E. R. Birnbaum, M. Brugh, S. Mirzadeh, K. D. John, M. E. Fassbender, Chuangyan Zhai, Gerben M. Franssen, Milos Petrik, Peter Laverman, Clemens Decristoforo, Ait-Mohand Samia…

    Citation: EJNMMI Radiopharmacy and Chemistry 2016 1(Suppl 1):10

    Published on:

    This article is part of a Supplement: Volume 1 Supplement 1

  6. Content type: Review

    Traditional nuclear medicine ligands were designed to target cellular receptors or transporters with a binding pocket and a defined structure–activity relationship. More recently, tracers have been developed t...

    Authors: Aleksandar Jovalekic, Norman Koglin, Andre Mueller and Andrew W. Stephens

    Citation: EJNMMI Radiopharmacy and Chemistry 2016 1:11

    Published on:

  7. Content type: Research

    213Bismuth (213Bi, T1/2 = 45.6 min) is one of the most frequently used α-emitters in cancer research. High specific activity radioligands are required for peptide receptor radionuclide...

    Authors: Ho Sze Chan, Erik de Blois, Mark W. Konijnenberg, Alfred Morgenstern, Frank Bruchertseifer, Jeffrey P. Norenberg, Fred J. Verzijlbergen, Marion de Jong and Wouter A. P. Breeman

    Citation: EJNMMI Radiopharmacy and Chemistry 2016 1:9

    Published on:

  8. Content type: Research

    Recently, 44Sc (T1/2 = 3.97 h, Eβ+ av = 632 keV, I = 94.3 %) has emerged as an attractive radiometal candidate for PET imaging using DOTA-functionalized biomolecules. The aim of this st...

    Authors: Katharina A. Domnanich, Cristina Müller, Renata Farkas, Raffaella M. Schmid, Bernard Ponsard, Roger Schibli, Andreas Türler and Nicholas P. van der Meulen

    Citation: EJNMMI Radiopharmacy and Chemistry 2016 1:8

    Published on:

  9. Content type: Research

    6-[18F]Fluoro-L-3,4-dihydroxyphenylalanine (FDOPA) is a frequently used radiopharmaceutical for detecting neuroendocrine and brain tumors and for the differential diagnosis of Parkinson’s disease. To meet the dem...

    Authors: G. Luurtsema, H. H. Boersma, M. Schepers, A. M. T. de Vries, B. Maas, R. Zijlma, E. F. J. de Vries and P. H. Elsinga

    Citation: EJNMMI Radiopharmacy and Chemistry 2016 1:7

    Published on:

  10. Content type: Research

    Typically, metal-based radiopharmaceuticals are synthesized in aqueous solutions with no or low ethanol content. Labeling yields are defined by temperature, period of labeling, amount of precursor, pH etc. As ...

    Authors: Elisabeth Eppard, Marylaine Pèrez-Malo and Frank Rösch

    Citation: EJNMMI Radiopharmacy and Chemistry 2016 1:6

    Published on:

  11. Content type: Letter to the Editor

    149Tb represents a powerful alternative to currently used α-emitters: the relatively short half-life (T1/2 = 4.1 h), low α-energy (3.97 MeV, Iα = 16.7 %), absence of α-emitting daughters ...

    Authors: Cristina Müller, Christiaan Vermeulen, Ulli Köster, Karl Johnston, Andreas Türler, Roger Schibli and Nicholas P. van der Meulen

    Citation: EJNMMI Radiopharmacy and Chemistry 2016 1:5

    Published on:

  12. Content type: Research

    Phosphodiesterase 10A (PDE10A) is an important regulator of nigrostriatal dopamine (DA) neurotransmission. However, little is known on the effect of alterations in DA neurotransmission on PDE10A availability. ...

    Authors: Maarten Ooms, Sofie Celen, Ronald De Hoogt, Ilse Lenaerts, Johnny Liebregts, Greet Vanhoof, Xavier Langlois, Andrey Postnov, Michel Koole, Alfons Verbruggen, Koen Van Laere and Guy Bormans

    Citation: EJNMMI Radiopharmacy and Chemistry 2016 1:3

    Published on:

  13. Content type: Research

    The widespread acceptance and application of 68Ga-PET depends on our ability to develop radiopharmaceuticals that can be prepared in a convenient and suitable manner. A kit-type labelling protocol provides such c...

    Authors: Johanna Seemann, Bradley Waldron, David Parker and Frank Roesch

    Citation: EJNMMI Radiopharmacy and Chemistry 2016 1:4

    Published on:

  14. Content type: Position paper

    This is a position paper of the Radiopharmacy Committee of the EANM (European Association of Nuclear Medicine) addressing toxicology studies for application of new diagnostic and therapeutic radiopharmaceutica...

    Authors: J. Koziorowski, M. Behe, C. Decristoforo, J. Ballinger, P. Elsinga, V. Ferrari, P. Kolenc Peitl, S. Todde and T. L. Mindt

    Citation: EJNMMI Radiopharmacy and Chemistry 2016 1:1

    Published on:

Page 2 of 2

Affiliated with

2017 Journal Metrics

  • Speed
    34 days from submission to first decision
    59 days from submission to acceptance
    22 days from acceptance to publication

    Usage 
    27,471 Downloads

Upcoming events

​​​​​​​EANM'18

Related websites

Searching for an article? Easily browse the EJNMMI journals on the Nuclear Medicine and Molecular Imaging webportal.

Advertisement